Question 1

Does Candriam S.C.A. own PTGX stock?

Accepted Answer

No. Candriam S.C.A. exited its PTGX (Protagonist Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 162,492 shares worth $7.3M.

Question 2

How many shares of PTGX does Candriam S.C.A. own?

Accepted Answer

None since Q4 2024, when Candriam S.C.A. exited the position. Its Q3 2024 13F listed 162,492 shares worth $7.3M.

Question 3

What is Candriam S.C.A.'s PTGX position worth?

Accepted Answer

Candriam S.C.A.'s PTGX position was worth $7.3M in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is Candriam S.C.A. buying or selling PTGX?

Accepted Answer

In Q4 2024, Candriam S.C.A. exited its entire PTGX position.

Question 5

When did Candriam S.C.A. first buy PTGX?

Accepted Answer

Candriam S.C.A. first reported PTGX in its Q2 2021 13F and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$38.60	0
2024-Q3	Decreased	162,492	-40.7%	$7.3M	0.0%	$45.00	0